Recursion Pharmaceuticals Inc (NASDAQ:RXRX) currently has a daily average trading volume of 21.18M but it saw 22671122 shares traded in last market. With a market cap of 1.66B USD, the company’s current market price of $4.09 came falling about -10.00 while comparing to the previous closing price of $4.55. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.36 and as low as $3.79.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which initiated the stock as “Equal-Weight” in its note to investors issued on May 22, 2023, recommending a price target of $8 for it. KeyBanc Capital Markets also issued its recommendations for the stock as it initiated the price target for the stock is $20.
Over the week, RXRX’s stock price is moving -4.99% down while it is -27.26% when we observe its performance for the past one month. Year-to-date it is -39.42% down and over the past year, the stock is showing a downside performance of -56.53%.
Currently, Recursion Pharmaceuticals Inc’s total number of outstanding shares is 399.15M with 3.14% of that held by the insiders while 78.28% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -57.11% and return on equity (ROE) at -86.10%. Stock’s beta reads 0.86. Stock has a price to book (P/B) ratio of 1.78 while price to sale or P/S ratio amounts to 27.84. Its return on asset (ROA) is -61.70% on average.
